The study focuses on the effects of fluvastatin on immunomarkers of the M1 and M2 macrophages and its direct role in macrophage (M0) polarization. Moreover, it investigates the dependency of immunomodulatory properties of fluvastatin on the mevalonate pathway. Macrophages (M0, M1, M2), differentiated from human blood monocytes, were treated with fluvastatin. Mevalonate and geranylgeranyl pyrophosphate intermediates were introduced to assess the mevalonate pathway dependence. The immunomarkers were evaluated with qPCR, ELISA, Griess assay, and flow cytometry. Fluvastatin significantly reduces the pro-inflammatory gene expression (NFκB, IL-1β, IL-6, iNOS) in M1 while enhancing the anti-inflammatory markers (Arg-1, TGFβ) in M2 macrophages. The production of the TNFα, IL-1β, and IL-6 cytokines is reduced in M1, and IL-10 production increased in M2 macrophages. Fluvastatin decreases the iNOS activity in M1 macrophages. The intermediates reverse the fluvastatin's effects on anti-inflammatory gene expression by M2 macrophages, cytokine production (by M1 and M2 macrophages), and iNOS activity (by M1 macrophages). Their impact on surface marker expression was somewhat limited. These findings demonstrate that fluvastatin exerts anti-inflammatory effects on polarized macrophages without affecting polarization per se and also highlight the dependency on the mevalonate pathway. This study deepens the understanding of statins' immunomodulatory mechanisms, suggesting potential applications in treating inflammatory diseases.

Department of Anesthesia and Intensive Medicine 1st Faculty of Medicine Charles University and University Military Hospital Prague Czech Republic

Department of Physiology Faculty of Science Charles University Prague Czech Republic

Laboratory for Atherosclerosis Research Centre for Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

See more in PubMed

Endo, A. The origin of the statins. Int. Congr. Ser.1262, 3–8 (2004).

Feldt, M. et al. The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: A window-of-opportunity breast cancer trial. Cancer Metab.10.1186/s40170-020-00231-8 (2020). PubMed PMC

Climent, E., Benaiges, D. & Pedro-Botet, J. Hydrophilic or lipophilic statins? Front. Cardiovasc. Med. (2021). PubMed PMC

Matyori, A., Brown, C. P., Ali, A. & Sherbeny, F. Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines. Saudi Pharm. J.31, 795–800 (2023). PubMed PMC

Ramkumar, S., Raghunath, A. & Raghunath, S. Statin therapy: Review of safety and potential side effects. Acta Cardiol. Sin.32(6), 631–639 (2016). PubMed PMC

Laakso, M. & Fernandes, S. L. Statins and risk of type 2 diabetes: Mechanism and clinical implications. Front. Endocrinol. (Lausanne).14, 20 (2023). PubMed PMC

Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med.359, 2195–207. 10.1056/NEJMoa0807646 (2008). PubMed

Li, H. et al. Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis. Mol. Cell. Neurosci.68, 284–292 (2015). PubMed

McFarland, A. J., Davey, A. K. & Anoopkumar-Dukie, S. Statins reduce lipopolysaccharide-induced cytokine and inflammatory mediator release in an in vitro model of microglial-like cells. Mediat. Inflamm.2017, 1–10 (2017). PubMed PMC

Jougasaki, M., Ichiki, T., Takenoshita, Y. & Setoguchi, M. Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. Br. J. Pharmacol.159, 1294–1303 (2010). PubMed PMC

Bahrami, A., Parsamanesh, N., Atkin, S. L., Banach, M. & Sahebkar, A. Effect of statins on toll-like receptors: A new insight to pleiotropic effects. Pharmacol. Res.135, 230–238 (2018). PubMed

Kauerova, S. et al. Statins directly influence the polarization of adipose tissue macrophages: A role in chronic inflammation. Biomedicines.9, 1–13 (2021). PubMed PMC

Xu, X. et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J. Neuroinflam.10.1186/s12974-017-0934-2 (2017). PubMed PMC

Stumpf, C. et al. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Clin. Sci.116, 45–52 (2009). PubMed

Yoshimura, K. et al. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue. Int. J. Mol. Sci.16, 11213–11228 (2015). PubMed PMC

Kadhim, S., Al-Windy, S., Al-Nami, M., Al-Kuraishy, H. & Al-Gareeb, A. Possible role of statins on the inflammatory biomarkers in patients with periodontal disease: A cross-sectional study. Dent. Hypotheses10, 70–75 (2019).

Sheridan, A., Wheeler-Jones, C. P. D. & Gage, M. C. The immunomodulatory effects of statins on macrophages. Immuno2(2), 317–343. 10.3390/immuno2020021 (2022).

Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther.8(1), 207 (2023). PubMed PMC

Ross, E. A., Devitt, A. & Johnson, J. R. Macrophages: The good, the bad, and the gluttony. Front. Immunol.10.3389/fimmu.2021.708186 (2021). PubMed PMC

Thaler, B. et al. Protease-activated receptors 1 and 3 are differentially expressed on human monocyte subsets and are upregulated by lipopolysaccharide ex vivo and in vivo. Thromb. Haemost.119, 1394–1402 (2019). PubMed

Narayan, N. et al. The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory ‘M1’ human macrophages. PLoS ONE12(10), e0185767. 10.1371/journal.pone.0185767 (2017). PubMed PMC

Hickman, E. et al. Expanded characterization of in vitro polarized M0, M1, and M2 human monocyte-derived macrophages: Bioenergetic and secreted mediator profiles. PLoS ONE18(3), e0279037. 10.1371/journal.pone.0279037 (2023). PubMed PMC

Fu, H. et al. The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation. Cell Death Dis.10.1038/s41419-019-2109-9 (2019). PubMed PMC

Guevara, I. et al. Determination of nitrite / nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta274(2), 177–188 (1998). PubMed

Arnaud, C. et al. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: New evidence for direct antiinflammatory effects of statins. Arterioscler. Thromb. Vasc. Biol.25, 1231–1236 (2005). PubMed

Tu, J. et al. Simvastatin Inhibits IL-1β-induced apoptosis and extracellular matrix degradation by suppressing the NF-kB and MAPK pathways in nucleus pulposus cells. Inflammation40, 725–734 (2017). PubMed

Crockett, S. D. et al. Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study. Inflamm. Bowel Dis.18, 1048–1056 (2012). PubMed PMC

Mora, S. & Ridker, P. M. Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (JUPITER) - Can C-reactive protein be used to target statin therapy in primary prevention? Am. J. Cardiol.97, 33–41 (2006). PubMed

Linnenberger, R., Hoppstädter, J., Wrublewsky, S., Ampofo, E. & Kiemer, A. K. Statins and bempedoic acid: Different actions of cholesterol inhibitors on macrophage activation. Int. J. Mol. Sci.22, 12480 (2021). PubMed PMC

Kuijk, L. M. et al. HMG-CoA reductase inhibition induces IL-1β release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood112(9), 3563–3573. 10.1182/blood-2008-03-144667 (2008). PubMed

Konat, G. W., Krasowska-Zoladek, A. & Kraszpulski, M. Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: Implication of Rho proteins in negative feedback regulation. J. Neurosci. Res.86, 603–609 (2008). PubMed

Alkakhan, W. et al. Statins modulate microenvironmental cues driving macrophage polarization in simulated periodontal inflammation. Cells12(15), 1961. 10.3390/cells12151961 (2023). PubMed PMC

Mylonas, K. S., Peroulis, M., Kapetanakis, E. I. & Kapelouzou, A. Myocardial expression of pluripotency, longevity, and proinflammatory genes in the context of hypercholesterolemia and statin treatment. J. Clin. Med.13(7), 1994. 10.3390/jcm13071994 (2024). PubMed PMC

Kavalipati, N., Shah, J., Ramakrishan, A. & Vasnawala, H. Pleiotropic effects of statins. Indian J. Endocrinol. Metab.19(5), 554. 10.4103/2230-8210.163106 (2015). PubMed PMC

Ma, W. et al. Statin function as an anti-inflammation therapy for depression in patients with coronary artery disease by downregulating interleukin-1β. J. Cardiovasc. Pharmacol.67(2), 129–135. 10.1097/FJC.0000000000000323 (2016). PubMed

Yang, N. et al. Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction. Cardiovasc. Ther.34, 234–244 (2016). PubMed

Kata, D. et al. Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells. Neuroscience314, 47–63 (2016). PubMed

Larson-Casey, J. L. et al. Increased flux through the mevalonate pathway mediates fibrotic repair without injury. J. Clin. Investig.129, 4962–4978 (2019). PubMed PMC

Xiao, A. et al. Statins affect human glioblastoma and other cancers through TGF-β inhibition. Available from: www.oncotarget.com PubMed PMC

Akula, M. K. et al. Control of the innate immune response by the mevalonate pathway. Nat. Immunol.17, 922–929 (2016). PubMed PMC

Gbelcová, H. et al. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells. Lipids Health Dis.10.1186/s12944-017-0641-0 (2017). PubMed PMC

Liu, Y. et al. Role of MCP-1 as an inflammatory biomarker in nephropathy. Front. Immunol. (2023). PubMed PMC

Ikeda, U., Shimpo, M., Ikeda, M., Minota, S. & Shimada, K. Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J. Cardiovasc. Pharmacol.38(1), 69–77. 10.1097/00005344-200107000-00008 (2001). PubMed

Dayal, S. et al. Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia. PLoS ONE9(9), e107734. 10.1371/journal.pone.0107734 (2014). PubMed PMC

Jürgens, D. C. et al. Efficient and targeted siRNA delivery to M2 macrophages by smart polymer blends for M1 macrophage repolarization as a promising strategy for future cancer treatment. ACS Biomater. Sci. Eng.10, 166–177 (2024). PubMed

Holstein, S. A., Wohlford-Lenane, C. L. & Hohl, R. J. Isoprenoids influence expression of Ras and Ras-related proteins. Biochemistry41, 13698–13704 (2002). PubMed

Makarevičius, G., Rinkūnienė, E. & Badarienė, J. National Trends in Statin Use in Lithuania from 2010 to 2021. Medicina (Lithuania)59, 37 (2023). PubMed PMC

Liu, Y. et al. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012–2018). BMC Cardiovasc. Disord.10.1186/s12872-020-01482-5 (2020). PubMed PMC

Fong, C. W. Statins in therapy: Understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. Eur. J. Med. Chem.85, 661–674 (2014). PubMed

Shitara, Y. & Sugiyama, Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol. Ther.112(1), 71–105 (2006). PubMed